Showing results (321-330 of 352) with videos related to
Sort By:
Pageof 36
The Oncologist|August 15, 2019
An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and ImmunotherapiesJingyu Cao, Lijuan Chen, Heng Li, et al.Elife|October 27, 2022
Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seqSara E Vazquez, Sabrina A Mann, Aaron Bodansky, et al.Neuro-Oncology|April 15, 2025
The novel brain penetrant ATM inhibitor WSD0628 provides robust radiosensitization of brain tumor patient derived xenograftsZhiyi Xue, Ann C Mladek, Sneha Rathi, et al.Circulation. Cardiovascular Genetics|December 4, 2010
Transforming growth factor-beta signaling pathway in patients with Kawasaki diseaseChisato Shimizu, Sonia Jain, Sonia Davila, et al.Journal of Neurotrauma|November 9, 2020
High-Sensitivity C-Reactive Protein is a Prognostic Biomarker of Six-Month Disability after Traumatic Brain Injury: Results from the TRACK-TBI StudyLinda B Xu, John K Yue, Frederick Korley, et al.Neurotrauma Reports|March 28, 2023
Neuroinflammatory Biomarkers for Traumatic Brain Injury Diagnosis and Prognosis: A TRACK-TBI Pilot StudyJohn K Yue, Firas H Kobeissy, Sonia Jain, et al.Neuro-Oncology Advances|September 8, 2022
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenograftsKendra A Porath, Michael S Regan, Jessica I Griffith, et al.JAMA Network Open|August 8, 2025
Vascular Risk Factors and 1-Year Cognitive Change Among Individuals With Traumatic Brain InjuryAndrea L C Schneider, Katherine J Hunzinger, Benjamin L Brett, et al.Journal of Neurotrauma|March 7, 2024
Isolated Traumatic Subarachnoid Hemorrhage on Head Computed Tomography Scan May Not Be Isolated: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study (TRACK-TBI) StudyJohn K Yue, Esther L Yuh, Mahmoud M Elguindy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2025
Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-Wild-type GlioblastomaRachael A Vaubel, Wenjuan Zhang, Ju-Hee Oh, et al.Pageof 36